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ABSTRACT Caveolae are non-clathrin-coated invaginations of the plasma mem-
brane, which are present in most cell types. An integral component of caveolae is the
caveolin family of related proteins, which not only forms the structural framework of
caveolae, but also likely subserves its functional roles, including regulation of signal
transduction and cellular transport, in particular, cholesterol trafficking. Although
caveolae have been identified ultrastructurally in the peripheral nervous system (PNS),
caveolin expression has not previously been studied. To date, three caveolin genes have
been reported. Here, we show for the first time that caveolin-1 is expressed by Schwann
cells (SC) as well as several SC-derived cell lines. Caveolin-1 is enriched in the buoyant,
detergent-insoluble membranes of rat sciatic nerve (SN) and SC, a hallmark of the
caveolar compartment. Caveolin-1 exists as both soluble and insoluble forms in rat SN
and SC, and localizes to SC cytoplasm and abaxonal myelin. SC caveolin-1 decreases
after axotomy, when SC revert to a premyelinating phenotype. We speculate that
caveolin-1 may regulate signal transduction and/or cholesterol transport in myelinating
SC. GLIA 27:39–52, 1999. r 1999 Wiley-Liss, Inc.
INTRODUCTION
Caveolae are plasma membrane microdomains that
can invaginate to form 50–100 nm vesicles, and are
enriched in cholesterol, glycosphingolipids, a variety of
signaling molecules, and the caveolins, a family of
18–24 kD proteins. There are four known structurally
homologous caveolin isoforms transcribed from three
separate genes (Glenney and Soppet, 1992; Scherer P et
al., 1996; Tang et al., 1996). Caveolin-1 consists of
21 kD and 24 kD isoforms derived from alternate
translational start sites, and it was the first character-
ized member of the caveolin family (Rothberg et al.,
1992). It is present in most cell types, but is especially
abundant in epithelial cells, fibroblasts, type I pneumo-
cytes, adipocytes, and smooth muscle cells (Lisanti et
al., 1994a, 1995a; Severs, 1988). Caveolin-1 is a mem-
brane protein that forms part of the cytoplasmic coat of
caveolae (Lisanti et al., 1993), interacting with itself to
form homo-oligomers (Fra et al., 1995b). Caveolin-2
(20 kD) has not been extensively studied, but has a
similar distribution to caveolin-1 (Scherer P et al.,
1996), with which it can form hetero-oligomeric com-
plexes (Scheiffele et al., 1998), whereas caveolin-3
(18 kD) is considered muscle-specific (Tang et al., 1996).
A number of functions are proposed for caveolae: (1)
the uptake of small molecules such as folate into cells, a
process known as potocytosis (Anderson et al., 1992);
(2) the transcytosis of molecules such as low density
lipoprotein across cells (Simionescu, 1983); (3) polar-
ized trafficking of proteins, especially in epithelial cells
(Simons and Wandinger-Ness, 1990); (4) cholesterol
transport (Murata et al., 1995); and (5) regulation of
signal transduction (Anderson, 1993; Lisanti et al.,
1994b, 1995c; Wu et al., 1997). A ‘‘caveolae signaling
hypothesis’’ proposes that compartmentalization of sig-
naling molecules within caveolae allows for efficient
coupling of activated receptors to a number of different
effector systems (Lisanti et al., 1994a; Okamoto et al.,
1998; Sargiacomo et al., 1993).
By virtue of its ability to self-oligomerize, caveolin
may serve a scaffolding role (Sargiacomo et al., 1995).
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Caveolin-1 directly binds cholesterol (Murata et al.,
1995) and possibly glycosphingolipids (Fra et al., 1995a;
Parton, 1994), both of which are abundant in caveolae
(Simionescu et al., 1983). The unique lipid microenviron-
ment of caveolae accounts for the insolubility of caveoale-
associated molecules in most nonionic detergents and
the low density of caveolae relative to other cellular
membranes, properties used to isolate caveolin-en-
riched membranes (CEMs) from a variety of cells and
tissues (Lisanti et al., 1995b; Song et al., 1996a). CEMs
are thought to be the biochemical counterparts of
caveolae and are thus enriched in a variety of signaling
molecules. For example, all of the following are concen-
trated within caveolae-like membranes: the receptors
for insulin (Mastick and Saltiel, 1997), platelet-derived
growth factor (Liu et al., 1996), the nerve growth
factors p75NTR (Bilderback et al., 1997) and trkB (Wu et
al., 1997), basic fibroblast growth factor (Gleizes et al.,
1996), epidermal growth factor (Smart et al., 1995),
bradykinin (B2) (Haasemann et al., 1998), and atrial
natriuretic peptide (type B) (Doyle et al., 1997). In
addition, caveolin-1 binds directly to the epidermal
growth factor receptor (Couet et al., 1997; Smart et al.,
1995), p75NTR (Bilderback et al., 1997), and a variety of
lipid-modified signaling molecules, such as Ras (Song et
al., 1996a), Src-like kinases (Li et al., 1996a), endothe-
lial nitric-oxide synthase (Shaul et al., 1996) and G-pro-
teins (Li et al., 1995).
Plasma membrane invaginations with the morpho-
logic appearance of caveolae are present in blood ves-
sels (Olsson and Reese, 1971), cells forming the perineu-
rial sheaths of the PNS (Akert et al., 1976; Hall and
Williams, 1971; Olsson and Reese, 1971; Reale et al.,
1975; Sandri et al., 1977; Waggener et al., 1965), and
SC (Mugnaini et al., 1977). However, caveolin expres-
sion within SC has not been explored. We have previ-
ously reported caveolin immunoreactivity in detergent-
insoluble fractions of rat SN (Mikol and Feldman,
1997). Here, we demonstrate that caveolin-1 is ex-
pressed by SC and is enriched in a low-density mem-
brane fraction using a detergent-free method to enrich
for CEMs. Caveolin-1 from SN or SC is present in both
soluble and membrane-associated forms and localizes
to SC cytoplasm and abaxonal myelin. Caveolin-1 immu-
noreactivity is significantly decreased after axotomy,




Rat SN and lung were purchased from Pel-Freez
(Rogers, AR) for immunoblotting. Adult rat SN was
frozen in OCT compound (Ted Pella, Inc., Redding, CA)
and sectioned for immunohistochemistry. Adult rat
teased SN fibers and transected SN (distal stumps
collected 12 days after axotomy) (Scherer S et al., 1995),
fixed in 4% paraformaldehyde, were generously pro-
vided by Dr. S. Scherer (University of Pennsylvania,
Philadelphia, PA). The mouse monoclonal antibody
(mAb) (C37120), the affinity-purified rabbit polyclonal
antibody (pAb) against caveolin-1, and anti-Fyn rabbit
pAb were purchased from Transduction Laboratories
(Lexington, KY). The anti-S100 mAb (S-2532) was
purchased from Sigma (St. Louis, MO), while the
anti-myelin basic protein (MBP) mAb was obtained
from Boehringer Mannheim (Indianapolis, IN). Dr. J.
Archelos (Max Planck Institute for Psychiatry,
München, Germany) kindly provided the anti-P0 mAb.
Anti-PMP-22 and anti-myelin associated glycoprotein
(MAG) rabbit pAbs were generous gifts from Dr. E.
Shooter (Stanford University, Stanford, CA) and Dr. J.
Salzer (New York University, New York, NY), respec-
tively.
Cell Culture
In general, all cells were grown at 37°C in a humidi-
fied atmosphere with 10% CO2. For analysis by SDS-
polyacrylamide gel electrophoresis (PAGE), cells were
grown to ,80% confluency and collected for protein
quantification. SH-SY5Y and SHEP human neuroblas-
toma cells and NIE-115 rat neuroblastoma cells were
kindly provided by Drs. S. Fisher, V. Castle, and S.
O’Shea, respectively, all at the University of Michigan.
PC12 cells (rat pheochromocytoma origin) and N2a
mouse neuroblastoma cells were purchased from Ameri-
can Type Culture Collections (Manassas, VA). PC12
cells were grown in RPMI 1640 medium with 5% fetal
bovine serum (FBS) and 10% horse serum, while N2a
cells were grown in minimal essential media plus 10%
FBS and supplemented with 1% nonessential amino
acids (Gibco BRL Products, Gaithersburg, MD). SH-
SY5Y, SHEP and NIE-115 cells were cultured in Dulbec-
co’s modified Eagle’s media (DMEM) plus 10% FBS. The
SV-40 immortalized SC line MT4H1 (Peden et al.,
1989), a gift from Dr. G. Tennekoon (University of
Pennsylvania), was grown in DMEM containing 10%
FBS, 100 µM ZnSO4, and 100 µg/ml G418, while S16,
S16Y, and S42, all generated by repetitive passaging of
rat SC in the laboratory of Dr. R. Quarles (National
Institutes of Health, Bethesda, MD; Sasagasako et al.,
1996), were grown in DMEM, 10% FBS, and 100 µg/ml
gentamycin. The SV-40 immortalized oligodendroglial
cell lines N19 and N20 (Verity et al., 1993), supplied by
Dr. A. Campagnoni (University of California at Los
Angeles, Los Angeles, CA), were grown in Ham’s F-12
media plus 10% Nu-serum (Collaborative-Becton Dick-
inson, Bedford, MA).
SC obtained from SN of 3-day-old Sprague Dawley
rats (Harlan-Sprague Dawley, Indianapolis, IN; Brockes
et al., 1979) were cultured on poly-L-lysine coated
plates and maintained in standard growth medium
consisting of DMEM with 10% FBS, supplemented with
6 mM L-glutamine, 2 µM forskolin and 10 µg/ml
pituitary extract (Sigma; Brockes et al., 1979; Porter et
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al., 1986). Cells were passaged upon confluency and
used for 4 passages. To test the effects of raised
intracellular cAMP levels on caveolin-1 expression, SC
were grown for 24–72 h in defined medium (Cheng et
al., 1998) with or without 2 µM forskolin. Rat dorsal
root ganglion cells isolated from E15 Sprague-Dawley
rat pups (Russell et al., 1998) and SC were co-cultured
on poly-L-lysine coated coverslips for 48 h in defined
medium plus 10 nM insulin like growth factor-I, which
has been shown to promote myelination (Cheng et al.,
1998).
Membrane Fractionation
Rat SN or SC were homogenized at 4°C in phosphate
buffered saline (PBS) plus 1 mM phenylmethylsulfonyl-
fluoride and protease inhibitor cocktail (Boehringer-
Mannheim), then centrifuged at 200,000 g for 1 h. After
separation, equal aliquots of the supernatant and pellet
were analyzed by Western blotting. CEMs were pre-
pared from rat SN or SC by discontinuous density
gradient centrifugation in the presence or absence of
detergent, using established procedures (see below). All
steps were carried out at 4°C. Briefly, ,10–15 adult SN
or two 150 mm plates of cultured SC were utilized per
centrifuge tube, whether the detergent-based or deter-
gent-free protocol was followed.
For preparation of low density, Triton-insoluble mem-
branes, the method of Lisanti (Lisanti et al., 1995b) was
used with minor modifications. The sample was homog-
enized in 3 ml 25 mM 2-(N-morpholino)ethane sulfonic
acid (pH 6.5) plus 0.15 M NaCl (MBS) containing 1%
Triton-X-100, 1 mM phenylmethylsulfonylfluoride and
protease inhibitor cocktail. After 8–10 strokes with a
Dounce homogenizer, 3 ml of lysate was combined 1:1
with 80% sucrose (in MBS) and placed at the bottom of
a centrifuge tube. A 5%–15%–25% step gradient (2 ml
each in MBS, without detergent) was layered above,
and the sample was centrifuged at 200,000 g for 20 h in
a SW 41 rotor (Beckman Instruments, Palo Alto, CA).
Twelve 1 ml fractions were collected (top to bottom) and
equal aliquots of these fractions plus the initial homog-
enate and pellet were analyzed by SDS-PAGE.
Detergent-free extractions were performed essen-
tially as described (Song et al., 1996a). Tissue or cells
were homogenized in 0.5 M sodium carbonate (pH 11.0)
using a Dounce homogenizer, followed by sonication
(three 20 sec bursts). The sample was then combined
1:1 with 80% sucrose (in MBS) and overlaid with a step
gradient of 5%–15%–25% sucrose (containing MBS plus
0.25 M sodium carbonate). Centrifugation and collec-
tion of aliquots were carried out as above for the
detergent-based method.
Electrophoresis and Western Blotting Analysis
Protein samples were quantified using a Protein
Assay kit (Bio-Rad Laboratories, Richmond, CA). Poly-
peptides and pre-stained molecular mass standards
(Amersham Life Science, Arlington Heights, IL) were
separated by SDS-PAGE (8%, 10%, or 12% acrylamide)
using the method of Laemmli (Laemmli, 1970) and
electrically transferred to nitrocellulose as previously
described (Mikol and Stefansson, 1988). To minimize
non-specific binding of antibodies, nitrocellulose sheets
were then blocked overnight in 5% nonfat dry milk or
4% bovine serum albumin (each in Tris-buffered saline
plus 0.05% Tween 20), for polyclonal and monoclonal
antibody immunoblotting, respectively. Antibodies were
diluted in the blocking solution to minimize non-
specific reactions. Nitrocellulose sheets were immuno-
blotted with mAb (1:2,000) or affinity-purified pAb
(1:4,000) against caveolin-1, pAb against Fyn (1:2,000),
MAG (1:10,000) or PMP-22 (1:2,000), or mAb against
MBP (1:2,000), followed by peroxidase-conjugated sec-
ondary antibodies (1:2,500; Santa Cruz Biotechnology,
Santa Cruz, CA) diluted in the appropriate blocking
solution. Both monoclonal and polyclonal anti-caveolin
antibodies were used to ensure specific binding to
caveolin-1. Immunoblots were visualized using en-
hanced chemiluminescence reagents. To verify specific
binding of antibody to caveolin-1, positive (lung lysate)
and negative (SY5Y cell lysate) controls were immunob-
lotted along with the SN or SC samples, and parallel
immunoblots were incubated in the absence of primary
antibody (conjugate control) for each antibody.
Immunohistochemistry and
Immunocytochemistry
Frozen sections of rat SN were brought to room
temperature prior to processing. Adult SN and transec-
ted SN sections, teased fibers and SC/dorsal root gan-
glion neuron co-cultures grown on poly-L-lysine-coated
coverslips were either fixed in 4% paraformaldehyde (in
PBS) for 15 min or immunostained without fixation.
Samples were permeabilized with either 0.1% Triton
X-100 (in PBS) for 20 min or acetone at 22°C for 10
min. After a 30 min incubation in blocking solution (2%
nonfat dry milk plus 0.1% Triton X-100 in PBS) to
minimize nonspecific binding of antibodies, samples
were incubated with primary antibody in blocking
solution for 24 h at 4°C. Antibodies against caveolin-1,
S100 and P0 were all used at 1:500. After washing with
PBS, a 6 h incubation with secondary antisera (1:100)
at room temperature followed, using either Cy-3 conju-
gated anti-rabbit or FITC-conjugated anti-mouse anti-
bodies (Jackson Immunoresearch, Westgrove, PA) in
blocking solution. In addition, conjugate controls (no
primary antibody) were done in parallel to demonstrate
that immunoreactivity was due to binding of primary
antibody. Slides were coverslipped and viewed by fluo-
rescence microscopy using a Leitz fluorovert micro-
scope (W. Nuhsbaum Inc., McHenry, IL).
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RESULTS
Caveolin-1 Expression in SC
and SC Derived Lines
We analyzed caveolin-1 expression in a number of
different neural cell lines derived from neuroblastoma
(N2a, SH-SY5Y, SHEP, NIE-115), pheochromocytoma
(PC12), oligodendrocytes (N19,N20), or SC (MT4H1,
S16, S16Y, S42) by immunoblotting cell lysates with an
affinity-purified anti-caveolin-1 pAb (Fig. 1A). The ap-
parent molecular weight of caveolin-1 is ,24 kD (size
markers not shown). Three exposures of the same
immunoblot are presented (with intentional overexpo-
sure of some lanes at 30 s and 8 min) to emphasize
relative caveolin-1 levels. Of the neural cell lines tested,
SC derived cell lines express the greatest levels of
caveolin-1. Within a class of comparable cell lines, the
cell line with the more differentiated phenotype, S16
compared to S16Y and S42 (Sasagasako et al., 1996)
and N20 compared to N19 (Verity et al., 1993), ex-
presses relatively more caveolin-1. SHEP and SH-SY5Y
cells are derived from the same parental neuroblas-
toma (Biedler et al., 1988). SHEP cells, which are more
differentiated and have been described as having a SC
phenotype, express abundant caveolin-1, whereas the
less differentiated SH-SY5Y cells, which have a neuro-
blastic phenotype, express no caveolin-1.
We next sought to identify caveolin-1 in rat SC.
Figure 1B shows that caveolin-1 is present both in a rat
SN homogenate, which contains a variety of cell types,
and in a pure lysate from cultured rat SC. A rat lung
lysate, which contains abundant caveolin-1, serves as a
positive control. In all of our experiments caveolin-1
from SN and cultured SC has a molecular weight of ,24
kD and co-migrates with caveolin-1 from rat lung.
CEMs from SC and SN
Two established protocols were used to isolate CEMs
from rat SN and cultured SC. The first protocol utilizes
detergent, while the second does not. In each case, thin
flocculent bands are visible with the naked eye at the
5%–15% and 15%–25% sucrose interfaces. Figure 2A
demonstrates that caveolin-1 from rat SN detergent
preparations is enriched in fractions 2 through 5, near
the 5%–15% and 15%–25% sucrose interfaces, which is
consistent with the buoyant characteristics of caveolin
from other tissues (Scherer P et al., 1996; Song et al.,
1996a,b). However, a considerable portion of caveolin-1
remains in the soluble 40% sucrose layer (fractions
7–12).
Because compact myelin membranes have a light
density (Norton and Poduslo, 1973) comparable to that
of CEMs, the above SN fractions were immunoblotted
with antibodies against several myelin proteins, includ-
ing MAG, MBP, P0, and PMP-22 (Fig. 2A), in order to
determine the usefulness of CEM preparations when
applied to nervous tissue. There is some variability in
the staining patterns, presumably reflecting differen-
tial detergent-solubilities of the myelin proteins. MAG
is largely present in the 40% sucrose layer (fractions
7–12), i.e., the original lysate layer, but is also present
to a lesser extent in fractions 3 and 4. In contrast, MBP
and P0 are present in most fractions. While these
results show that caveolin-1 and the compact myelin
protein PMP-22 are enriched in similar fractions, this is
likely due to the similar buoyant characteristics of
CEMs and myelin membranes. We do not detect signifi-
cant caveolin-1 in compact myelin membranes isolated
by the method of Norton and Poduslo (1973; data not
shown). Thus, density-based methods used to enrich for
CEMs from nervous tissue are limited by the compa-
rable densities of CEMs and myelin membranes, which
results in their co-purification.
Detergent-free preparation of CEMs from SN and SC
lysates again reveals enrichment of caveolin-1 within
fractions around the 5%–15% and 15%/25% sucrose
interfaces (Fig. 2B). These SC cultures are not myelina-
ting, implying that the CEMs here are equivalent to
typical caveolae-like membranes (Song et al., 1996a).
Once again, caveolin-1 is detected in the lower sucrose
fractions from both SN and SC, which indicates that a
fraction of caveolin-1 is soluble in buffer alone. Figure
2C illustrates how SN and SC caveolin-1 partitions into
soluble and membrane-associated forms.
The nonreceptor tyrosine kinase Fyn is concentrated
within caveolae (Lisanti et al., 1995a). Caveolin-1 inter-
acts directly with Fyn and other Src-like kinases,
inhibiting their activity (Li et al., 1996a). Because Fyn
mediates integrin downstream signaling and anchorage-
dependent growth in fibroblasts (Wary et al., 1998) and
Fig. 1. Caveolin-1 expression in SC derived cell lines and SC. A: Cell
lysates (50 µg) from a number of neural cell lines were immunoblotted
with anti-caveolin-1 (Cav-1) pAb. Three exposures (increasing expo-
sure time from top to bottom) are shown in order to illustrate the
relative levels of caveolin-1 expression. The SC lines (MT4H1, S16 and
S16Y, and S42) express caveolin-1, although there is some variability
in the amounts expressed. The SC-like cell line SHEP expresses
abundant caveolin-1, whereas SH-SY5Y cells, derived from the same
neuroblastoma, have no detectable caveolin-1. One oligodendrocyte
cell line (N20) expresses caveolin-1, while N19 and several neuronal-
like cell lines (PC12, N2a, NIE-115, SH-SY5Y) have minimal to no
detectable caveolin-1. B: Rat SN (20 µg), SC (50 µg) and lung (L) (0.2
µg) were immunoblotted with anti-caveolin-1 pAb. The results demon-
strate the presence of caveolin-1 in all lysates. The apparent molecular
weight of caveolin-1 is ,24 kD (not shown).
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Fig. 2. CEMs from rat SN. A: Rat SN was homogenized and
subjected to discontinuous sucrose gradient centrifugation in the
presence of Triton X-100. Equal aliquots of the initial homogenate (H),
insoluble pellet (P), or fractions 1 through 12 (top to bottom) were
analyzed by SDS-PAGE, followed by immunoblotting. Caveolin-1
(Cav-1) is enriched in low density membranes (fractions 2 through 5),
although it is also detected in the higher density sucrose and pellet
fractions. For comparison, the same fractions were immunoblotted
with antibodies against several myelin proteins: MAG, MBP, P0, and
PMP-22. B: Rat SN or SC was homogenized and subjected to sucrose
gradient centrifugation in the absence of detergent. Equal aliquots of
the initial homogenate (H), insoluble pellet (P), or fractions 1 through
12 were analyzed by SDS-PAGE, followed by immunoblotting with
anti-caveolin-1 or anti-Fyn pAb (Fyn). Again, caveolin-1 is enriched in
the low density membranes (fractions 2 through 5), although small
amounts are again detected in the higher density sucrose and pellet
fractions. Fyn is enriched in similar buoyant membrane fractions from
SN. C: Rat SN or SC was homogenized in PBS and centrifuged at high
speed in order to identify soluble and membrane-associated forms of
caveolin-1. Equal volume aliquots of the initial homogenate (H), or
200,000 g supernatant (S), or pellet (P) from rat SN or SC were
separated by SDS-PAGE and immunoblotted with anti-caveolin-1
pAb. A soluble form of caveolin-1 is detected in both SN and SC,
although it appears to be more prevalent in the SN sample.
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some of the downstream signaling events necessary for
myelination in the central nervous system (Umemori et
al., 1994), it is possible that Fyn plays a role in PNS
myelination. We were unable to detect Fyn in cultured
SC (data not shown). However, using either method to
prepare CEMs from SN, Fyn is highly concentrated
within the buoyant fractions that are also enriched in
caveolin-1. Figure 2B demonstrates an anti-Fyn immu-
noblot of a detergent-free CEM preparation from SN.
Caveolin-1 Localization in Rat SN
Vesicles with the appearance of caveolae were identi-
fied ultrastructurally in peripheral nerve two decades
ago. Most of these studies described such vesicles in
perineurium and blood vessels (Akert et al., 1976; Hall
and Williams, 1971; Olsson and Reese, 1971; Reale et
al., 1975; Sandri et al., 1977; Waggener et al., 1965),
although a single report described them in SC (Mug-
naini et al., 1977). Using an affinity-purified anti-
caveolin-1 pAb to stain SN, SC and abaxonal myelin are
strongly immunostained, with additional staining of
the perineurium and blood vessels (Figs. 3–6). Cross
sections reveal caveolin-1 immunoreactivity of SC cyto-
plasm, while the abaxonal localization is most apparent
on longitudinal sections. Cytoplasmic caveolin-1 immu-
noreactivity overlaps with the S100 staining pattern
(Fig. 3). Double immunostaining with antibodies against
caveolin-1 and P0 demonstrates that there is no caveo-
lin-1 staining of compact myelin (data not shown).
Caveolin-1 immunostaining of adult SN teased fibers
localizes to SC cytoplasm (including paranodes) and
abaxonal myelin, but in addition reveals a stippled
appearance (Fig. 4). Such punctate caveolin-1 immuno-
reactivity suggests the distribution of caveolae (Roth-
berg et al., 1992). S100 immunostaining of teased fibers
shows a similar staining of SC cytoplasm, but without
the stippled pattern seen in the case of caveolin-1.
Immunofluorescent staining of cultured SC (Fig. 5A)
and SC/dorsal root ganglion co-cultures (Fig. 5B), using
the same caveolin-1 pAb, intensely labels SC, whereas
neurons and their axons do not visibly stain. The
staining pattern is punctate over the entirety of the
cells, along stress fibers, and at the cell margins. The
SC membrane is strongly caveolin-1 immunoreactive
where it contacts axons.
We have shown here that caveolin-1 is expressed in
PNS myelin. We questioned whether caveolin-1 expres-
sion might be affected by in vivo axonal cues, such as
nerve transection, which down-regulates myelin genes
(Mirsky and Jessen, 1990; Scherer et al., 1993), or
elevated intracellular cAMP, which induces expression
of myelin genes in vitro (Jessen et al., 1991; Lemke and
Chao, 1988). We chose to look at SC caveolin-1 levels 12
days after nerve transection, as myelin protein expres-
sion declines considerably by this time (Scherer S et al.,
1995). Figure 6A,C shows that SC caveolin-1 expression
decreases significantly after axotomy; perineurium and
blood vessels retain intense caveolin-1 immunoreactiv-
ity, which serves as an internal control. P0 is detected
12 days after axotomy in myelin debris (Fig. 6B,D). SC
persist and are S100 positive (not shown).
We also questioned whether caveolin-1 expression by
SC was affected in vitro by forskolin, which raises
intracellular cAMP, mimicking in part axonal contact
and thereby inducing expression of myelin genes such
as P0 (Lemke and Chao, 1988). We conducted several
experiments exposing SC to 2 µM forskolin, with incu-
bation varying between 24 and 72 h. In every case, P0
expression increases in the presence of 2 µM forskolin,
whereas caveolin-1 levels are unaltered. Figure 6E
shows the effects of forskolin treatment (for 24 h) on
caveolin-1 and P0 expression by cultured SC. Thus,
caveolin-1 expression is associated with a myelinating
phenotype but does not appear to be coordinately linked
with the expression of myelin genes.
DISCUSSION
The caveolins are increasingly being implicated in
such diverse biological processes as signal transduc-
tion, cellular transport, differentiation, and apoptosis
(for review see Okamoto et al., 1998). However, caveolin
has been little studied in the nervous system. We
questioned whether caveolin-1 was expressed in SC
and their differentiated organelle, myelin. Here, we
have identified caveolin-1 in a rat SN homogenate,
which contains a number of different cell types, in SC
derived cell lines, and in a pure SC lysate (Fig. 1).
Of the neural cell lines tested, the SC derived cell
lines (MT4H1, S16, S16Y, S42) express the greatest
levels of caveolin-1, and cell lines with more differenti-
ated phenotypes express relatively more caveolin-1
(Biedler et al., 1988; Sasagasako et al., 1996; Verity et
al., 1993; Fig. 1A). Although they were both derived
from a single human neuroblastoma (Biedler et al.,
1988), the SH-SY5Y and SHEP cell lines show differen-
tial caveolin-1 expression. SHEP cells, which have
some characteristics of SC, tend to be relatively slow
growing, have a finite life-span in vitro, are anchorage
and serum dependent, and do not typically form tumors
in nude mice. In contrast, SH-SY5Y cells have neuro-
blastic characteristics, divide more readily, are anchor-
age and serum independent, and readily form tumors in
nude mice. SHEP cells express abundant caveolin-1
whereas SH-SY5Y cells have no detectable caveolin-1.
Of course, caution must be used in interpreting these
results, as protein expression in cell lines is not neces-
sarily representative of protein expression in primary
cells in vitro or in vivo. Nonetheless, these results are
consistent with previous findings that associate caveo-
lin expression with a differentiated cellular state (Fan
et al., 1983; Scherer P et al., 1995; Song et al., 1996b).
The caveolins are most abundantly expressed in
terminally differentiated cells such as muscle cells,
endothelial cells, and adipocytes. For example, caveo-
lin-1 levels increase as much as 25-fold when NIH3T3
fibroblasts differentiate into adipocytes (Fan et al.,
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Fig. 3. Caveolin-1 localization in rat SN. Rat SN sections were
permeabilized with 0.1% Triton X-100 and double immunostained
with pAb against caveolin-1 (Cav-1) (A,C) and mAb against S100
(B,D). The cross sections (A,B) reveal crescent-shaped caveolin-1
immunoreactivity of SC cytoplasm (arrowheads). Longitudinal sec-
tions (C,D) demonstrate caveolin-1 staining in a linear fashion that is
consistent with immunoreactivity of abaxonal myelin (arrows) as well
as SC cytoplasm (arrowheads). Perineurium (p) is also immunoreac-
tive for caveolin-1. The pattern of S100 immunostaining of SC
cytoplasm (arrowheads) overlaps with that of caveolin-1. Scale bar 5
20 µM.
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Fig. 4. Caveolin-1 immunostaining of rat SN teased fibers. Rat SN
teased fibers were immunostained with pAb against caveolin-1 (Cav-1)
(A,B) or mAb against S100 (C). Double immunostaining of the same
fibers with caveolin-1 and S100 is illustrated in (B) and (C). Caveolin-1
is strongly localized in the outer myelin membrane (arrows) and SC
cytoplasm (SC). Caveolin-1 is also found at the paranodes (arrow-
heads). Caveolin-1 immunoreactivity has a stippled appearance, most
apparent in (A), which was permeabilized with cold acetone. (B) and
(C) were permeabilized with 0.1% Triton X-100. Caveolin-1 and S100
are both detected in SC cytoplasm. Scale bar 5 10 µM.
46 MIKOL ET AL.
1983; Scherer P et al., 1995), and caveolin-3 expression
increases substantially during differentiation of C2C12
myoblasts into myotubes (Song et al., 1996b). In con-
trast, cellular transformation results in decreased lev-
els of caveolin and caveolae (Engelman et al., 1997;
Koleske et al., 1995). Caveolin expression in trans-
formed cells leads to suppression of the transformed
phenotype (Engelman et al., 1998b; Lee et al., 1998),
with loss of anchorage independent growth (Engelman
et al., 1997). The mechanisms for the effects of caveolins
on growth control are being elucidated. It appears that
caveolins function largely as negative regulators of
signal transduction, e.g., by suppressing MAP kinase
activity (Engelman et al., 1997, 1998a) and signaling
through the Neu receptor (Engelman et al., 1998b), the
epidermal growth factor receptor, and protein kinase C
(Couet et al., 1997). However, caveolin may stimulate
other signal transducing molecules, such as the insulin
receptor (Yamamoto et al., 1998). Thus, regulated caveo-
lin expression by SC may in part determine their
responsiveness to growth factors, and ultimately, their
phenotype.
Clearly, caveolin is an essential structural protein of
caveolae, and its expression is sufficient to drive the
formation of caveolae-like vesicles. Cells that contain
abundant caveolae, such as adipocytes, endothelial
cells, smooth muscle cells, and fibroblasts also express
the highest levels of caveolin (Glenney, 1992; Lisanti et
al., 1994b). Furthermore, within a given cell type
expressing caveolin-1, the degree of caveolin-1 expres-
sion correlates with the number of caveolae (Fan et al.,
1983; Koleske et al., 1995; Scherer P et al., 1994; 1996).
Recombinant expression of caveolin in cell lines with-
out detectable caveolin, or identifiable caveolae, results
in caveolin enrichment within caveolae-like mem-
branes and the de novo formation of caveolae (Fra et al.,
1995b; Scherer P et al., 1995). Thus, the presence of a
caveolin in SC likely drives the formation of caveolae,
and we therefore aniticipated that caveolin-1 would be
present in CEMs from SN and SC (Fig. 2).
CEMs can be prepared on the basis of their low
density and detergent-insolubility. They share many of
the features of caveolae (Lisanti et al., 1995b; Song et
al., 1996a), including enrichment in cholesterol, as well
Fig. 5. Caveolin-1 immunostaining of SC in vitro. Rat SC (A) or
co-cultures of SC/dorsal root ganglion neurons harvested 48 h after
plating in the presence of insulin like growth factor-I (B) were
immunostained with anti-caveolin-1 (Cav-1) pAb, after first permeabil-
izing cells with 0.1% Triton X-100. Strong SC staining is evident,
especially at cell margins (A, arrows) and where SC membranes abut
axons (B, arrowheads), whereas axons do not appreciably stain. In (A),
scale bar 5 20 µM; in (B), scale bar 5 10 µM.
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as glycosphingolipids and a variety of signal-transduc-
ing components (Lisanti et al., 1994b; Montesano et al.,
1982; Parton, 1994; Sargiacomo et al., 1993). Because
detergent-based methods to prepare CEMs are suscep-
tible to potential artifacts, such as apparent enrich-
ment in glycosylphosphatidylinositol-anchored pro-
teins (Schnitzer et al., 1995), we also used an established
detergent-free protocol to prepare CEMs from rat SN
and SC. Using either method, caveolin-1 is enriched in
a buoyant membrane fraction (fractions 2 through 5) of
SN and SC (Fig. 2A,B). The Src-like kinase Fyn, which
is known to be enriched in caveolae (Lisanti et al.,
1995a), is concentrated within overlapping fractions
from SN. While SN preparations are complicated by the
presence of compact myelin, which has a comparable
light density, nonmyelinating SC cultures also show
enrichment of caveolin-1 in buoyant fractions, i.e.,
CEMs.
Fig. 6. Axonal influences on caveolin-1 expression. Rat SN collected
12 days after nerve transection were permeabilized with 0.1% Triton
X-100 and double immunostained with pAb against caveolin-1 (Cav-1)
(A,C) and P0 (B,D). Cross sections are shown in (A) and (B), while
longitudinal sections are shown in (C) and (D). SC caveolin-1 expres-
sion is reduced significantly (compare to Fig. 3), while perineurial (p)
and blood vessel (v) caveolin-1 staining remain intense. P0 is detected
in myelin debris (arrows); areas of P0 immunoreactivity are indicated
in panels (A–D, arrows). Scale bars 5 20 µM. E: SC were cultured in
serum-free defined medium with (1) or without (2) 2 µM forskolin for
24 h, and cell lysates were immunoblotted with anti-P0 mAb or
anti-caveolin-1 pAb. P0 increases with forskolin treatment whereas
caveolin-1 expression is unaffected.
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Immunohistochemically, caveolin-1 is detected in SC
cytoplasm and abaxonal myelin (Figs. 3 and 4), which
may correspond to soluble and insoluble forms of caveo-
lin-1, respectively (Fig. 2C). The cytoplasmic localiza-
tion of caveolin-1 is readily apparent when compared to
the similar staining pattern of S100. Adult SN teased
fibers and cultured SC immunostained for caveolin-1
demonstrate a stippled appearance of immunoreactiv-
ity (Figs. 4 and 5), which has been noted in other cell
types and likely correlates with the distribution of
caveolae (Cameron et al., 1997; Rothberg et al., 1992;
Scherer, P. et al., 1995). We have previously shown that
SC align along axons by 48 h in SC/dorsal root ganglion
neuron co-cultures treated with insulin like growth
factor-I (Cheng et al., 1998). Here, we find that after 48
h of co-culture, the SC membrane is strongly caveolin-1
immunoreactive where it abuts axons (Fig. 5B), which
could reflect compartmentalized signal transduction at
the intial stage of myelination. Although Galbiati et al.
(1998) have recently identified caveolin expression in
the cell bodies and growth cones of dorsal root ganglion
neurons, we did not observe caveolin-1 immunostaining
of axons.
SC phenotype is controlled by downstream signaling
effects of the extracellular matrix (Bunge et al., 1986;
Eldridge et al., 1989), cell–cell adhesion events (Owens
and Bunge, 1989; Wood et al., 1990), and growth factors
(Brockes et al., 1980; Cheng et al., 1998; Davis and
Stroobant, 1990; Goodearl et al., 1993; Hansson et al.,
1986; Krasnoselsky et al., 1994; Ridley et al., 1989).
When premyelinating SC contact axons during develop-
ment, they align on and ensheath axons (Webster,
1993). Myelin formation follows attainment of a one-to-
one ratio between SC and large axons, and is accompa-
nied by SC expression of myelin genes such as P0, MBP,
and MAG (Jessen et al., 1991) and suppression of SC
proliferation (Jessen and Mirsky, 1991). After nerve
transection, with loss of axonal signals, SC revert to a
premyelinating phenotype and no longer express my-
elin genes (Mirsky and Jessen, 1990; Scherer et al.,
1993, 1996). Figures 6A–D shows that SC caveolin-1
expression decreases substantially after nerve transec-
tion. Caveolin-1 staining of blood vessels and perineu-
rium remains intense, while SC staining declines (see
Fig. 3 for comparison). Our preliminary results show
that caveolin-1 is also developmentally regulated, con-
cordant with the onset of myelination (not shown). In
non-neural cells, caveolin-1 expression is associated
with differentiation in sensescent cells, as well as with
cell death in cells that are rapidly dividing (Engelman
et al., 1997; Wary et al., 1996). Caveolin-1 might play an
analagous role regarding the fate of developing SC,
which either cease proliferation and begin to differenti-
ate in response to axonal signals or undergo cell death
(Grinspan et al., 1996; Jessen et al., 1994; Nakao et al.,
1997; Stewart et al., 1996; Syroid et al., 1996).
Recently, caveolin-1 has been shown to mediate an-
chorage dependent growth in fibroblasts by serving as a
membrane adaptor protein, linking integrins to Fyn
(Wary et al., 1998). Fyn is concentrated within caveolar
membranes (Lisanti et al., 1995a) and likely binds
caveolin directly (Li et al., 1996a). Although Fyn has
not been extensively studied in the PNS, it appears to
be involved in the signaling events that occur during
the early stages of myelination in the central nervous
system (Umemori et al., 1994). Thus, increased caveo-
lin-1 expression in differentiated cells may reflect the
effects of the extracellular matrix on growth arrest and
differentiation. Extrapolation of these results into SC
allows one to speculate that myelination in the PNS
might require signaling pathways that involve the
extracellular matrix, caveolin-1 and Fyn. Caveolin-1’s
abaxonal localization is consistent with its possible role
mediating integrin signaling.
The effects of axonal contact upon SC can be partially
mimicked in vitro by elevating cAMP levels (Lemke and
Chao, 1988). That is, SC expression of myelin genes
such as P0, MBP, and MAG increases upon cAMP
elevation. We did not find any difference in SC expres-
sion of caveolin-1 after treatment with 2 µM forskolin
for 24–72 h, whereas P0 expression increased under
this condition. Figure 6E shows the effects of forskolin
on SC expression of P0 and caveolin-1 after 24 h. These
data suggest that caveolin-1 expression is regulated by
other factors and is not directly linked to the transcrip-
tion of myelin genes.
There is growing evidence that sterol levels control
caveolin-1 expression at the level of transcription (Bist
et al., 1997; Fu et al., 1998). At the same time, caveo-
lin-1 may itself regulate cholesterol efflux in fibroblasts,
with the expression of caveolin-1 varying in response to
cellular cholesterol content (Fielding and Fielding,1995,
1997b; Fielding et al., 1997a). Interestingly, hydroxy-
methylglutaryl-coenzyme A reductase, the rate-limit-
ing enzyme in cholesterol biosynthesis, is upregulated
in parallel with myelination, yet this enzyme is also
unaffected by elevated cAMP levels (Fu et al., 1998).
Rather, it is regulated primarily by the intracellular
sterol concentration (Fielding et al., 1997a; Fu et al.,
1998; Holthuizen et al., 1990). Although caveolin-1 is
thought to be a membrane protein, a considerable
portion of caveolin-1 from SN or SC is soluble in buffer
alone (Fig. 2C). These results are interesting in light of
the recent findings by Uittenbogaard et al. (1998), who
have identified a soluble heat-shock protein–caveolin–
chaperone complex in NIH 3T3 cells that transports
newly synthesized cholesterol en route to caveolar
membranes by a vesicle-independent mechanism.
Soluble caveolin-1 in SN and SC might be similarly
associated with newly synthesized cholesterol. We de-
tect a larger fraction of soluble caveolin-1 in SN than in
cultured SC (Fig. 2C), perhaps reflecting the greater
need for cholesterol synthesis in myelin forming SC.
It is unknown whether caveolin-1 mediates choles-
terol transport in SC, whose cholesterol is entirely
endogenous, but caveolin-1 expression could facilitate
cholesterol trafficking and ultimately myelin synthesis.
Given that cholesterol binds caveolin-1 (Murata et al.,
1995), accounts for roughly 25% of myelin lipids (Dewille
and Horrocks, 1992), is entirely derived from locally
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synthesized sources in peripheral nerve (Jurevics and
Morell, 1994; Jurevics et al., 1998), and is essential for
the proper structure and function of caveolae (Hail-
stones et al., 1998; Li et al., 1996b; Rothberg et al.,
1990; 1992), it is plausible that caveolin-1 might regu-
late cholesterol trafficking during myelination and re-
myelination.
In summary, caveolin-1 is expressed by SC. Caveo-
lin-1 exists in soluble and membrane associated forms,
and is localized to SC cytoplasm and abaxonal myelin
membranes. Caveolin-1 is expressed in myelinating SC
but decreases after axotomy, when SC revert to a
premyelinating phenotype. We postulate that caveo-
lin-1 may regulate signal transduction and/or choles-
terol transport in myelin forming SC.
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